Winchester, MA, United States of America

Rulin Ma

This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignee: Celgene Corporation. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rulin Ma. Retrieved from https://idiyas.com/inventor/rulin-ma-g7mb3n3r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rulin Ma: Innovator in Neurodegenerative Disease Treatment

Introduction

Rulin Ma is a notable inventor based in Winchester, MA, who has made significant contributions to the field of neurodegenerative disease treatment. With a focus on innovative compounds, he has developed solutions aimed at improving the lives of those affected by neurological disorders.

Latest Patents

Rulin Ma holds a patent for "Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases." This patent provides compounds and compositions designed for modulating S1P5, which are intended for the treatment of various neurological diseases. His work in this area highlights the potential for new therapeutic approaches to combat these challenging conditions.

Career Highlights

Rulin Ma is currently associated with Celgene Corporation, where he continues to advance his research and development efforts. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Rulin has collaborated with esteemed colleagues, including Jeffrey M Schkeryantz and Karin Irmgard Worm, to further enhance the impact of his research. These partnerships reflect the collaborative spirit that drives innovation in the medical field.

Conclusion

Rulin Ma's contributions to the treatment of neurodegenerative diseases through his innovative patent work exemplify the importance of research and collaboration in advancing medical science. His ongoing efforts at Celgene Corporation continue to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…